Alfonso Serrano
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Clusterin in disease pathology
Papers in
- Immunology 10
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 5
- T-cell and B-cell Immunology 3
- Oncology 4
- Clusterin in disease pathology 4
- Co-authors
- Thierry Boon (4 shared papers)Etienne De Plaen (4 shared papers)Maximino Redondo (6 shared papers)Charles De Smet (1 shared paper)Bernard Lethé (2 shared papers)Danièle Godelaine (1 shared paper)Sophie Lucas (1 shared paper)Francisco Ruiz‐Cabello (4 shared papers)
- Journals
- International Journal of Cancer (4 papers)Anti-Cancer Drugs (1 paper)Cancers (1 paper)New England Journal of Medicine (1 paper)Current Protein and Peptide Science (1 paper)
- Partner nations
- SpainBelgiumSwitzerland
In The Last Decade
Alfonso Serrano
15 papers receiving 613 citations
Peers
Comparison fields: 5 of 73
- Immunology 420
- Oncology 175
- Molecular Biology 283
- Nutrition and Dietetics 24
- Radiology, Nuclear Medicine and Imaging 32
Countries citing papers authored by Alfonso Serrano
This map shows the geographic impact of Alfonso Serrano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfonso Serrano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfonso Serrano more than expected).
Fields of papers citing papers by Alfonso Serrano
This network shows the impact of papers produced by Alfonso Serrano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfonso Serrano. The network helps show where Alfonso Serrano may publish in the future.
Co-authors
The 25 scholars most cited alongside Alfonso Serrano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 230 | |
| 2 | 1999 | 67 | |
| 3 | 2003 | 52 | |
| 4 | 1981 | 48 | |
| 5 | 1996 | 43 | |
| 6 | 1999 | 36 | |
| 7 | 2007 | 35 | |
| 8 | 1999 | 28 | |
| 9 | 2018 | 26 | |
| 10 | 2011 | 24 | |
| 11 | 2000 | 23 | |
| 12 | 2009 | 15 | |
| 13 | 1995 | 5 | |
| 14 | 2014 | 4 | |
| 15 | 1999 | 1 |
About Alfonso Serrano
Alfonso Serrano is a scholar working on Immunology, Oncology, Molecular Biology, Immunology and Allergy and Cancer Research, having authored 15 papers that have together received 637 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (5 papers), Clusterin in disease pathology (4 papers), RNA Interference and Gene Delivery (3 papers), vaccines and immunoinformatics approaches (3 papers), T-cell and B-cell Immunology (3 papers), Epigenetics and DNA Methylation (2 papers) and Cell Adhesion Molecules Research (1 paper). The work is most often cited by research in Immunology (420 citations), Oncology (175 citations), Molecular Biology (283 citations), Nutrition and Dietetics (24 citations) and Radiology, Nuclear Medicine and Imaging (32 citations). Alfonso Serrano has collaborated with scholars based in Spain, Belgium and Switzerland. Frequent co-authors include Thierry Boon, Etienne De Plaen, Maximino Redondo, Charles De Smet, Bernard Lethé, Danièle Godelaine, Sophie Lucas, Francisco Ruiz‐Cabello, Federico Garrido and Ronald A. Malt. Their work appears in journals such as International Journal of Cancer, Anti-Cancer Drugs, Cancers, New England Journal of Medicine and Current Protein and Peptide Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.